643
Participants
Start Date
January 18, 2024
Primary Completion Date
August 21, 2025
Study Completion Date
December 11, 2025
Amlitelimab
Pharmaceutical form: Injection solution Route of administration: SC injection
Placebo
Pharmaceutical form: injection solution Route of administration: SC injection
Topical corticosteroids
Pharmaceutical form: Topical formulation Route of administration: Topical
Topical calcineurin inhibitors
Pharmaceutical form: Topical formulation Route of administration: Topical
Investigational Site Number : 0320011, Buenos Aires
Investigational Site Number : 0320019, Buenos Aires
Investigational Site Number : 0320008, Buenos Aires
Investigational Site Number : 0320018, Buenos Aires
Investigational Site Number : 0320010, Buenos Aires
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320005, CABA
Investigational Site Number : 1002009, Sofia
Investigational Site Number : 1002006, Sofia
Investigational Site Number : 1002007, Dupnitsa
Investigational Site Number : 0320012, Corrientes
Investigational Site Number : 0320020, San Miguel de Tucumán
Investigational Site Number : 0320013, Mendoza
Investigational Site Number : 1002004, Pleven
Equity Medical- Site Number : 8401239, New York
Icahn School of Medicine at Mount Sinai- Site Number : 8401129, New York
OptiSkin- Site Number : 8401163, New York
Vial Health - DermDox Dermatology- Site Number : 8401031, Camp Hill
Investigational Site Number : 7240019, Granada
Investigational Site Number : 2760017, Hamburg
Investigational Site Number : 3800003, Milan
Investigational Site Number : 2760021, Hamburg
Investigational Site Number : 2760014, Buxtehude
Investigational Site Number : 2762208, Kiel
Investigational Site Number : 2500010, Romans-sur-Isère
Investigational Site Number : 7920008, Gaziantep
Investigational Site Number : 7240013, Madrid
Clinical Research Center of the Carolinas- Site Number : 8401067, Charleston
Cleaver Medical Group- Site Number : 8401138, Dawsonville
Investigational Site Number : 7240015, Pamplona
Investigational Site Number : 2500002, Toulouse
Investigational Site Number : 2500011, Bordeaux
Palm Springs Community Health Center- Site Number : 8401264, Miami Lakes
Skin Care Research - Hollywood- Site Number : 8401071, Hollywood
Clever Medical Research- Site Number : 8401160, Miami
Acevedo Clinical Research Associates- Site Number : 8401088, Miami
University of South Florida- Site Number : 8401070, Tampa
Avita Clinical Research- Site Number : 8401073, Tampa
Global Clinical Professionals (GCP)- Site Number : 8401045, St. Petersburg
Investigational Site Number : 7920003, Istanbul
Investigational Site Number : 7920005, Istanbul
Investigational Site Number : 7920006, Istanbul
Investigational Site Number : 7920002, Istanbul
Investigational Site Number : 7920009, Istanbul
Cahaba Dermatology & Skin Health Center- Site Number : 8401066, Birmingham
Investigational Site Number : 7240014, Vigo
Investigational Site Number : 7920004, Kayseri
Investigational Site Number : 2760018, Magdeburg
Investigational Site Number : 3800012, Bologna
Investigational Site Number : 7240020, Seville
Investigational Site Number : 2500009, Nantes
Apex Clinical Research Center- Site Number : 8401237, Mayfield Heights
Investigational Site Number : 7240023, Burjassot
Dawes Fretzin Clinical Research- Site Number : 8401015, Indianapolis
Investigational Site Number : 7242502, Manises
Investigational Site Number : 7240008, Bilbao
Oakland Medical Center- Site Number : 8401116, Troy
Investigational Site Number : 2762201, Münster
Allergy & Immunology Associates of Ann Arbor- Site Number : 8401078, Ypsilanti
Investigational Site Number : 2760009, Bad Bentheim
Investigational Site Number : 2760016, Mainz
Investigational Site Number : 7920007, Samsun
Investigational Site Number : 3800008, Pisa
Investigational Site Number : 2760019, Witten
Investigational Site Number : 3800019, Torette
NorthShore University HealthSystem - Skokie Hospital- Site Number : 8401038, Skokie
Dermatology and Skin Cancer Lee's Summit- Site Number : 8401157, Lee's Summit
Investigational Site Number : 3800011, L’Aquila
Skin Specialists- Site Number : 8401068, Omaha
Investigational Site Number : 2500006, Pierre-Bénite
BRCR Global Gretna- Site Number : 8401243, Gretna
Velocity Clinical Research - New Orleans- Site Number : 8401155, New Orleans
Johnson Dermatology- Site Number : 8401076, Fort Smith
Essential Medical Research- Site Number : 8401183, Tulsa
SMS Clinical Research- Site Number : 8401182, Mesquite
Investigational Site Number : 2500012, Rouen
Sienna Dermatology- Site Number : 8401148, Missouri City
Complete Dermatology - Sugar Land- Site Number : 8401061, Sugar Land
Texas Dermatology and Laser Specialists- Site Number : 8401131, San Antonio
Discovery Clinical Trials - San Antonio - Stone Oak Parkway- Site Number : 8401026, San Antonio
Cope Family Medicine - Ogden Clinic- Site Number : 8401114, Bountiful
Tanner Clinic - Layton Antelope A- Site Number : 8401151, Layton
Investigational Site Number : 2760020, Augsburg
Jubilee Clinical Research- Site Number : 8401054, Las Vegas
LA Universal Research Center- Site Number : 8401064, Los Angeles
Encino Research Center- Site Number : 8401042, Encino
Marvel Clinical Research- Site Number : 8401102, Huntington Beach
Southern California Dermatology- Site Number : 8401043, Santa Ana
Cura Clinical Research- Site Number : 8401141, Palmdale
Integrative Skin Science and Research- Site Number : 8401275, Sacramento
Investigational Site Number : 2500016, Saint-Pierre
Investigational Site Number : 1560041, Shenyang
Investigational Site Number : 1560005, Shanghai
Investigational Site Number : 1560003, Wuxi
Investigational Site Number : 1560047, Tianjin
Investigational Site Number : 1560044, Hangzhou
Investigational Site Number : 1560006, Hangzhou
Investigational Site Number : 1560051, Nanchang
Investigational Site Number : 1560043, Fuzhou
Investigational Site Number : 1560050, Changsha
Investigational Site Number : 1560049, Wuhan
Investigational Site Number : 1560021, Guangzhou
Investigational Site Number : 1560060, Chengdu
Investigational Site Number : 1520006, Viña del Mar
Investigational Site Number : 1520012, Talcahuano
Investigational Site Number : 1520009, Osorno
Investigational Site Number : 1520008, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520010, Santiago
Investigational Site Number : 1520011, Santiago
Investigational Site Number : 1520005, Santiago
Investigational Site Number : 1520001, Santiago
Allcutis Research - Portsmouth- Site Number : 8401082, Portsmouth
Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760017, Vitória
Centro de Pesquisas da Clínica IBIS- Site Number : 0760002, Salvador
PUC Trials- Nucleo de Pesquisa clinica da Escola de Medicina da PUCPR- Site Number : 0760023, Curitiba
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760005, Porto Alegre
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760024, Porto Alegre
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760015, Ribeirão Preto
Faculdade de Medicina do ABC- Site Number : 0760001, Santo André
Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760010, São Paulo
Hospital das Clinicas FMUSP- Site Number : 0760012, São Paulo
Investigational Site Number : 1240039, Calgary
Investigational Site Number : 1240045, Red Deer
Investigational Site Number : 1240046, Kamloops
Investigational Site Number : 1240030, Surrey
Investigational Site Number : 1240041, Winnipeg
Investigational Site Number : 1240057, Brampton
Investigational Site Number : 1241106, Markham
Investigational Site Number : 1240008, Mississauga
Investigational Site Number : 1240004, Peterborough
Investigational Site Number : 1240038, Richmond Hill
Investigational Site Number : 1240012, Toronto
Investigational Site Number : 1241107, Waterloo
Investigational Site Number : 1240006, Québec
Investigational Site Number : 2032105, Nový Jičín
Investigational Site Number : 2030010, Olomouc
Investigational Site Number : 2032104, Ostrava
Investigational Site Number : 2030009, Pilsen
Investigational Site Number : 2030008, Prague
Investigational Site Number : 2030008, Prague
Investigational Site Number : 2030011, Prague
Investigational Site Number : 2500013, Nice
Investigational Site Number : 3920009, Chitose
Investigational Site Number : 3923114, Obihiro
Investigational Site Number : 3920008, Sapporo
Investigational Site Number : 3920006, Kobe
Investigational Site Number : 3920005, Sagamihara
Investigational Site Number : 3923113, Yokohama
Investigational Site Number : 3923113, Yokohama
Investigational Site Number : 3920010, Miyagi-gun
Investigational Site Number : 3920011, Sendai
Investigational Site Number : 3923110, Sakai
Investigational Site Number : 3920002, Iruma
Investigational Site Number : 3923106, Mibu
Investigational Site Number : 3920004, Chūō
Investigational Site Number : 3923107, Minato
Investigational Site Number : 3920001, Tachikawa
Investigational Site Number : 3923109, Habikino
Investigational Site Number : 3923108, Kagoshima
Investigational Site Number : 3923102, Kyoto
Investigational Site Number : 3920003, Kyoto
Investigational Site Number : 7240010, Esplugues de Llobregat
Investigational Site Number : 7242505, Alicante
Investigational Site Number : 7920010, Ankara
Investigational Site Number : 7920001, Antalya
Lead Sponsor
Sanofi
INDUSTRY